1. How Old is Too Old to Operate for Mesothelioma?

   • Justin M. Karush

   Thoracic Oncology 10 May 2019 Pages: 2311 - 2312

2. Does a Lymph Node-Based Model Predict Clinical Value for Adjuvant Therapy in Squamous Cell Carcinoma of the Esophagus Treated With Upfront Surgery?

   • Dana McCloskey
   • David D. Shersher

   Thoracic Oncology 11 June 2019 Pages: 2313 - 2315

3. Sentinel Node Biopsy After Neoadjuvant Systemic Therapy for Breast Cancer: The Method Matters

   • Harry D. Bear
   • Kandace P. McGuire

   Breast Oncology 24 April 2019 Pages: 2316 - 2318

4. Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence, Technically Feasible but Influence on Oncologic Outcomes Yet to be Completely Defined

   • James W. Jakub

   Breast Oncology 29 April 2019 Pages: 2319 - 2321

5. Let’s Not Forget About Regional Therapy for the Treatment of Locally Advanced Extremity Melanoma

   • Giorgos C. Karakousis

   Melanoma 06 May 2019 Pages: 2322 - 2324

6. Resolve the Conflict Rather than Dissolve the Relationship

   • Sandra L. Wong
   • Steven C. Stain

   Health Services Research and Global Oncology 03 June 2019 Pages: 2325 - 2326

7. Changing Trends in Industry Funding for Surgical Oncologists

   • Juan A. Santamaria-Barria
   • Stacey Stern
   • Anton Bilchik

   Health Services Research and Global Oncology 29 April 2019 Pages: 2327 - 2335

   

8. Palliative Care and Symptom Burden in the Last Year of Life: A Population-Based Study of Patients with Gastrointestinal Cancer

   • Shaila J. Merchant
   • Susan B. Brogly
   • Nancy N. Baxter

   Health Services Research and Global Oncology 09 April 2019 Pages: 2336 - 2345

   

9. ASO Author Reflections: Managing Symptoms at the End-of-Life—Some Progress, Many Unanswered Questions

   • Shaila J. Merchant

   ASO Author Reflections 29 May 2019 Pages: 2346 - 2347

10. Contemporary Improvements in Postoperative Mortality After Major Cancer Surgery are Associated with Weakening of the Volume-Outcome Association

    • Nabil Wasif
    • David Etzioni
    • Yu-Hui Chang

    Health Services Research and Global Oncology 07 May 2019 Pages: 2348 - 2356

    

11. Management of Malignant Pleural Mesothelioma in the Elderly Population

    • Vivek Verma
    • Rodney E. Wegner
    • Charles B. Simone II

    Thoracic Oncology 22 April 2019 Pages: 2357 - 2366

    

12. Predicting the Value of Adjuvant Therapy in Esophageal Squamous Cell Carcinoma by Combining the Total Number of Examined Lymph Nodes with the Positive Lymph Node Ratio

    • Yida Li
    • Weixin Zhao
    • Zhengfei Zhu

    Thoracic Oncology 11 June 2019 Pages: 2367 - 2374

    

13. The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma

    • Sander J. M. van Hootegem
    • B. Mark Smithers
    • Andrew P. Barbour

    Thoracic Oncology Open access 02 April 2019 Pages: 2375 - 2384

    

14. Predicting the Risk of Weight Loss After Esophageal Cancer Surgery

    • Anna Schandl
    • Joonas H. Kauppila
    • Pernilla Lagergren

    Thoracic Oncology Open access 19 April 2019 Pages: 2385 - 2391

    

15. Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy

    • Jie Qian
    • Jianlin Xu
    • Baohui Han

    Thoracic Oncology 22 April 2019 Pages: 2392 - 2400

    

16. Tumor Volume Is Better Than Diameter for Predicting the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer

    • Hao-jun Xie
    • Xu Zhang
    • Xiao-dong Su

    Thoracic Oncology 03 May 2019 Pages: 2401 - 2408

    

17. The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial

    • So-Youn Jung
    • Jai Hong Han
    • Seeyoun Lee

    Breast Oncology 07 May 2019 Pages: 2409 - 2416

    

18. Low Risk of Development of a Regional Recurrence After an Unsuccessful Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor Recurrence

    • Ingrid G. M. Poodt
    • Coco J. E. F. Walstra
    • the Sentinel Node And Recurrent Breast Cancer (SNARB) study group

    Breast Oncology 08 March 2019 Pages: 2417 - 2427

19. Multicenter Phase II Study of Intraoperative Radiotherapy of Early Breast Cancer: Ipsilateral Tumor Recurrence

    • Masataka Sawaki
    • Takeshi Miyamoto
    • Hiroji Iwata

    Breast Oncology 16 April 2019 Pages: 2428 - 2434

    

20. Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study

    • André Hennigs
    • Fabian Riedel
    • Jörg Heil

    Breast Oncology 02 May 2019 Pages: 2435 - 2443

    

21. Psychosocial Functioning in Women with Early Breast Cancer Treated with Breast Surgery With or Without Immediate Breast Reconstruction

    • Helene Retrouvey
    • Isabel Kerrebijn
    • Toni Zhong

    Breast Oncology 06 May 2019 Pages: 2444 - 2451

    

22. Pretreatment Tattoo Marking of Suspicious Axillary Lymph Nodes: Reliability and Correlation with Sentinel Lymph Node

    • Rupa Patel
    • Wendy MacKerricher
    • Irene L. Wapnir

    Breast Oncology 13 May 2019 Pages: 2452 - 2458

    

23. Oncoplastic Level 2 Mammoplasty for Large DCIS: 5-Year Results

    • R. F. D. van la Parra
    • K. B. Clough
    • C. Nos

    Breast Oncology 13 May 2019 Pages: 2459 - 2465

    

24. Single-Incision Approach for Breast-Conserving Surgery: Effectiveness, Complications and Quality of Life

    • Benigno Acea-Nebril
    • Alejandra García-Novoa
    • Joaquín Mosquera-Oses

    Breast Oncology 17 May 2019 Pages: 2466 - 2474

    

25. Role of Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Study from the Japanese Breast Cancer Registry

    • Minoru Miyashita
    • Naoki Niikura
    • Yutaka Tokuda

    Breast Oncology 17 May 2019 Pages: 2475 - 2485

    

26. Long–Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis

    • John T. Miura
    • Hidde M. Kroon
    • Jonathan S. Zager

    Melanoma 25 March 2019 Pages: 2486 - 2494

    

27. ASO Author Reflections: International Experience of Isolated Limb Infusion for Melanoma Shows Durable Response

    • John T. Miura
    • Hidde M. Kroon
    • Jonathan S. Zager

    ASO Author Reflections 13 May 2019 Pages: 2495 - 2496

28. For Patients with Early Rectal Cancer, Does Local Excision Have an Impact on Recurrence, Survival, and Quality of Life Relative to Radical Resection?

    • Amy L. Halverson
    • Arden M. Morris
    • George J. Chang

    Colorectal Cancer 25 April 2019 Pages: 2497 - 2506

    

29. Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer

    • Tsuyoshi Konishi
    • Eiji Shinozaki
    • Kensei Yamaguchi

    Colorectal Cancer 08 April 2019 Pages: 2507 - 2513

30. The Pelvis-First Approach for Robotic Proctectomy in Patients with Redundant Abdominal Colon

    • Yun Yang
    • Songphol Malakorn
    • Y. Nancy You

    Colorectal Cancer 17 May 2019 Pages: 2514 - 2515

31. Laparoscopic Complete Mesocolic Excision for Double Flexural Colon Cancers

    • Takeru Matsuda
    • Hiroshi Hasegawa
    • Yoshihiro Kakeji

    COLORECTAL CANCER 29 March 2019 Pages: 2516 - 2516

32. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group

    • Alexandra G. Lopez-Aguiar
    • Mohammad Y. Zaidi
    • Shishir K. Maithel

    Endocrine Tumors 19 April 2019 Pages: 2517 - 2524

    

33. The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors

    • Aaron T. Scott
    • Daniel Pelletier
    • James R. Howe

    Endocrine Tumors 22 April 2019 Pages: 2525 - 2532

    

34. Papillary Thyroid Cancers with Focal Tall Cell Change are as Aggressive as Tall Cell Variants and Should Not be Considered as Low-Risk Disease

    • Pim J. Bongers
    • Wouter P. Kluijfhout
    • Jesse D. Pasternak

    Endocrine Tumors 21 May 2019 Pages: 2533 - 2539

    

35. Para-aortic Lymphadenectomy for Gynecologic Cancers: Introducing the “Trans-Retro-Peritoneal (TRP) Single-Port Access”

    • Loïc Lelievre
    • Patrice Mathevet

    Gynecologic Oncology Open access 23 April 2019 Pages: 2540 - 2541

36. Elective Paratracheal Lymph Node Dissection in Salvage Laryngectomy

    • Janice L. Farlow
    • Andrew C. Birkeland
    • Matthew E. Spector

    Head and Neck Oncology 04 March 2019 Pages: 2542 - 2548

    

37. Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma

    • Liang-Shuo Hu
    • Xu-Feng Zhang
    • Timothy M. Pawlik

    Hepatobiliary Tumors 24 April 2019 Pages: 2549 - 2557

    

38. ASO Author Reflections: Understanding Recurrence Patterns and Time Courses of Intrahepatic Cholangiocarcinoma After Surgery Helps in Postoperative Surveillance and Treatment

    • Timothy M. Pawlik

    ASO Author Reflections 10 May 2019 Pages: 2558 - 2559

39. Predictors and Cumulative Frequency of Hepatocellular Carcinoma in High and Intermediate LI-RADS Lesions: A Cohort Study from a Canadian Academic Institution

    • Ephraim Shin-Tian Tang
    • Grayson Hall
    • Sulaiman Nanji

    Hepatobiliary Tumors 25 April 2019 Pages: 2560 - 2567

    

40. Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular Carcinoma

    • Hidetoshi Nitta
    • Marc-Antoine Allard
    • René Adam

    Hepatobiliary Tumors 03 May 2019 Pages: 2568 - 2576

    

41. Full Laparoscopic Anatomical Segment 8 Resection for Hepatocellular Carcinoma Using the Glissonian Approach with Indocyanine Green Dye Fluorescence

    • Giammauro Berardi
    • Go Wakabayashi
    • Kou Nishikawa

    Hepatobiliary Tumors 07 May 2019 Pages: 2577 - 2578

42. Intraoperative Air Leak Test to Prevent Bile Leak After Right Posterior Sectionectomy with En Bloc Diaphragm Resection for Metastatic Teratoma

    • Timothy J. Vreeland
    • Eve Beaudry Simoneau
    • Ching-Wei D. Tzeng

    Hepatobiliary Tumors 07 May 2019 Pages: 2579 - 2579

43. Clinical Importance of Sputum in the Respiratory Tract as a Predictive Marker of Postoperative Morbidity After Esophagectomy for Esophageal Cancer

    • Naoya Yoshida
    • Atsushi Morito
    • Hideo Baba

    Gastrointestinal Oncology 29 May 2019 Pages: 2580 - 2586

    

44. Proton Radiotherapy for Isolated Local Recurrence of Primary Resected Pancreatic Ductal Adenocarcinoma

    • Takuya Mizumoto
    • Kazuki Terashima
    • Takumi Fukumoto

    Pancreatic Tumors 30 May 2019 Pages: 2587 - 2594

    

45. RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score

    • A. Arjona-Sanchez
    • L. Rodriguez-Ortiz
    • J. Briceño

    Peritoneal Surface Malignancy 20 May 2019 Pages: 2595 - 2604

    

46. ASO Author Reflections: Tending Towards a Personalized Medicine for Colorectal Carcinomatosis by Adding the RAS Mutation Status in the Workup for CRS and HIPEC

    • A. Arjona-Sanchez
    • Lidia Rodriguez-Ortiz

    ASO Author Reflections 19 April 2019 Pages: 2605 - 2606

47. Discordant Diagnostic Terminology and Pathologic Grading of Primary Appendiceal Mucinous Neoplasms Reviewed at a High-Volume Center

    • Haroon A. Choudry
    • Reetesh K. Pai
    • David L. Bartlett

    Peritoneal Surface Malignancy 20 May 2019 Pages: 2607 - 2614

    

48. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP)

    • Israel Manzanedo
    • Fernando Pereira
    • José Gil Martínez

    Peritoneal Surface Malignancy 21 May 2019 Pages: 2615 - 2621

    

49. Preoperative Nutrition Status and Postoperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    • Lauren Reece
    • Helen Dragicevich
    • David L. Morris

    Peritoneal Surface Malignancy 23 May 2019 Pages: 2622 - 2630

50. A Combination of Positive Tumor HLA-I and Negative PD-L1 Expression Provides an Immune Rejection Mechanism in Bladder Cancer

    • José Francisco Flores-Martín
    • Francisco Perea
    • Natalia Aptsiauri

    Translational Research and Biomarkers 22 April 2019 Pages: 2631 - 2639